9/12/2013

About $86 billion worth of branded drugs will lose patent protection between 2013 and 2017, compared with $101 billion worth of drugs that lost patent protection between 2008 and 2012, according to IMS. Biologic drugs losing patent protection may present an opportunity for other drugmakers to gain market share, but some U.S. states have passed laws restricting substitution of biosimilar drugs.

Full Story:
Drug Store News

Related Summaries